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ABSTRACT High resolution atomic force microscopy is a powerful tool to characterize nanoscale morphological features of
protein amyloid ﬁbrils. Comparison of ﬁbril morphological properties between studies has been hampered by differences in
analysis procedures and measurement error determination used by various authors. We describe a ﬁbril morphology analysis
method that allows for quantitative comparison of features of amyloid ﬁbrils of any amyloidogenic protein measured by atomic
force microscopy. We have used tapping mode atomic force microscopy in liquid to measure the morphology of ﬁbrillar
aggregates of human wild-type a-synuclein and the disease-related mutants A30P, E46K, and A53T. Analysis of the images
shows that ﬁbrillar aggregates formed by E46K a-synuclein have a smaller diameter (9.0 6 0.8 nm) and periodicity (mode at 55
nm) than ﬁbrils of wild-type a-synuclein (height 10.0 6 1.1 nm; periodicity has a mode at 65 nm). Fibrils of A30P have smaller
diameter still (8.1 6 1.2 nm) and show a variety of periodicities. This quantitative analysis procedure enables comparison of the
results with existing models for assembly of amyloid ﬁbrils.
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The misfolding of proteins is at the heart of many human
diseases (see, for example, (1–4)). In Parkinson’s disease, the
misfolding and subsequent aggregation of the natively
unfolded protein a-synuclein is an essential factor (5). In
familial forms of Parkinson’s disease, three point mutations
in the a-synuclein gene have been identiﬁed that result in
single amino acid substitutions in the a-synuclein protein:
A30P, E46K, and A53T (6–8). Differences in the aggrega-
tion kinetics and/or aggregate morphology among the mutant
proteins may yield new insights into the general process of
protein misfolding and aggregation.
The nanoscale morphology of amyloid ﬁbrils can be
visualized with atomic force microscopy (AFM) or electron
microscopy (see, for example, (9,10)). The aggregation of
a-synuclein into mature ﬁbrils has been described by models
based on AFM images (11) and is supposed to proceed
through various stages, each with characteristic morpholog-
ical features such as typical ﬁbril heights and periodicities.
Although there are many studies on the morphology of
ﬁbrillar aggregates of various amyloidogenic proteins, there
has been little uniformity in the analysis and description of
ﬁbril characteristics (11). In this Letter, we describe a quan-
titative analysis procedure that is applicable to atomic force
micrographs of amyloid ﬁbrils originating from any amyloid-
ogenic protein. The procedure (Fig. 1) takes into account the
limitations of the physical process of imaging a biological
sample with atomic force microscopy, such as tip-sample
convolution.
We applied the quantitative image analysis procedure to
AFM images (made in tapping mode and in liquid) of ﬁbrils
of wild-type and mutant a-synuclein formed after 72 h of
aggregation (13). The analysis reveals grossly similar mor-
phology but varying heights and periodicities among the
disease-related mutants (Table 1). Fibrils from A30P and
E46K a-synuclein appear smaller in height and correspond-
ingly lower in peak height, trough height, and modulation
depth than wild-type ﬁbrils. Height measurements of wild-
type a-synuclein ﬁbrils in this study are consistent with those
measured by others. We measure 10.0 6 1.1 nm average
height for the ﬁbrils formed by wild-type a-synuclein, as
compared to 11 6 2 nm (14) and 9.8 6 1.2 nm (11).
Most E46K ﬁbrils display a periodicity of around 55 nm
(as in Fig. 2 A), but much larger periodicities (Fig. 2 B) or
unperiodic ﬁbrils (Fig. 2 C) are also observed. The periodic-
ities of E46K and wild-type a-synuclein ﬁbrils have modes
at 55 and 65 nm, respectively, and ﬁbrils formed by A30P
a-synuclein display a wider variety of periodicities (Fig. 3).
Quantitative discussion of morphological features of
objects studied by AFM requires consideration of the inﬂu-
ence of scanning system properties on the resulting image.
One of the main limiting factors in deriving ﬁbril properties
from AFM images is tip-sample convolution, as evidenced
by the large difference between the apparent width and the
height of ﬁbrils that are expected to be approximately round
in cross section.
To assess the reliability of the measured parameters, we
use a simple one-dimensional model for tip-sample convo-
lution (Fig. 4). From Fig. 4 A, it follows that the tip radius is
rt¼ w2/16rs, and the lowest measurable trough height can be
calculated based on Fig. 4 B (see Supplementary Material).
In the case of our a-synuclein ﬁbrils, the trough height is
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overestimated in the images since the tip radius is large rela-
tive to the periodicity. This complicates attributing the observed
periodicity to a supposed helical structure of the ﬁbrils. We
consider the measurements of the periodicity to be reliable
since they were found to be equivalent for ﬁbrils in any
orientation with respect to the scan direction, and because the
tip radius does not affect the periodicity observed but only
the modulation depth, as shown in Fig. 4 B.
In the hierarchical assembly model of a-synuclein ﬁbril
formation, as proposed by Khurana et al. (11), the trough
height would be yt ¼ (3/2)d, where d is the protoﬁbril
diameter (equal to the radius of the mature ﬁbril rs). We can
now compare the trough height values as modeled with the
tip-sample convolution model, as modeled with the hierar-
chical assembly model, and as actually measured, for two
ﬁbrils with a different periodicity (Table 2). Based on this
comparison, we conclude that the morphological features we
observe are those one would expect of ﬁbrils formed by
twisted protoﬁbrils, but we note that the lateral resolution of
our images is not high enough to prove unambiguously that
this model is indeed correct.
This study introduces a quantitative morphological anal-
ysis procedure of ﬁbrillar aggregates of amyloidogenic pro-
teins. We show that high-resolution atomic force microscopy
under sample-favorable imaging conditions (imaging under
buffer, low tapping amplitude (;4 nm), and low interac-
tion force), combined with detailed image analysis, allows
nanoscale comparison of ﬁbrils formed by human wild-type
a-synuclein and disease-related a-synuclein mutants. The
TABLE 1 Quantitative comparison of ﬁbril morphology of disease-related a-synuclein mutants
Protein variant N ﬁbrils Fibril height (nm) Typical trough height (nm) Typical peak height (nm) Modulation depth (nm) Periodicity (nm)
a-Synuclein wt 35 (22) 10.0 6 1.1 9.3 6 1.3 11.4 6 1.2 2.1 6 0.6 81 6 24 (mode 65 nm)y
a-Synuclein A30P 26 (21) 8.1 6 1.2 7.4 6 1.4 8.9 6 1.4 1.7 6 0.6 103 6 20
a-Synuclein E46K 26 (17) 9.0 6 0.8 7.7 6 1.0 9.8 6 1.1 2.0 6 0.5 76 6 34 (mode 55 nm)
a-Synuclein A53T 0*
N ﬁbrils is the number of ﬁbrils analyzed for a given mutant, with the number of ﬁbrils classiﬁed as periodic in brackets. All fragments were proﬁled and
characterized individually as described in Fig. 1. Those ﬁbril fragments not classiﬁed as periodic were irregular in height. Height values are averaged over all
N ﬁbrils; the other parameters are averaged over the periodic ﬁbrils. The standard deviation is used as the measurement error.
*In our experiment, a-synuclein A53T did not aggregate into ﬁbrils but into large amorphous aggregates (.1 mm diameter) that could not be characterized.
yFor a more accurate representation of the range of periodicities, see the histogram in Fig. 3.
FIGURE 1 Amyloid ﬁbril characterization procedure applied
to an E46K a-synuclein ﬁbril. The top panel shows an AFM
topography image of an a-synuclein ﬁbril (left panel) with a
manually drawn (ImageJ (12)) segmented line proﬁle (right panel)
on the curved ﬁbril. The bottom panel shows the corresponding
height along the proﬁle. The length ab is considered the ﬁbril
length (a and b are placed just inside the ramp-up and ramp-
down, which are ignored because of tip-sample convolution).
The reported ﬁbril height is the average height between a and b.
The periodicity of the ﬁbril is calculated as the distance cd
divided by, in this case, 15 periods. The ‘‘typical’’ peak and
trough heights are indicated by e and f. Finally, the height
difference ef is the measured modulation depth (see Fig. 4 for
comments on the interpretation). There is a certain subjectivity in
the choice of which peaks to consider ‘‘typical’’, due to the
limited spatial resolution of the image (in this case, the lateral
resolution is 11 nm/pixel) and due to possible peak height
variations in the ﬁbril itself.
FIGURE 2 Tapping mode atomic force micrograph of E46K
a-synuclein in liquid after 72 h of aggregation. The color scale
represents 17.6 nm in height. The ﬁbril fragments marked A, B,
and C are proﬁled along their length in the bottom panel indi-
cating the range of morphologies observed in E46K ﬁbrils.
Vertical scale bar 2 nm; horizontal scale bar, 200 nm.
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ﬁbrils formed by the disease-related mutants have a similar
overall morphology, but a smaller diameter and a different
periodicity than ﬁbrils formed by wild-type a-synuclein. The
observed ﬁbril morphology is compatible with the hierar-
chical assembly model of a-synuclein ﬁbrillization described
in Khurana et al. (11). We emphasize that great care should
be taken in deriving structural models from AFM data. We
believe that the careful quantitative approach to determining
ﬁbril morphological characteristics reported here should be
used more widely, and will be of increasing importance
considering the growing number of studies that use advanced
scanning probe microscopies for nanometer scale character-
ization of ﬁbrils.
SUPPLEMENTARY MATERIAL
An online supplement to this article can be found by visiting
BJ Online at http://www.biophysj.org.
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FIGURE 3 Distribution of periodicities in ﬁbrils of disease-
related a-synuclein mutants. Wild-type and E46K a-synuclein
ﬁbrils have modes at 65 and 55 nm, respectively. A30P shows a
wider variety of periodicities. Histogram bin size is 10 nm.
FIGURE 4 Simple one-dimensional models for tip-sample con-
volution for helical ﬁbrils. Fig. 4 A allows calculation of the tip
radius assuming the tip (green) is spherical and the sample (red)
has a spherical cross section (see Supplementary Material). Fig.
4 Bmodels the apparent trough height for a tip with given radius
scanning along the length of a double helical ﬁbril. rt, tip radius;
rs, sample radius; w, apparent width; o, contact point; c, tip
center; t, apparent trough position; and p, periodicity.
TABLE 2 Comparison of measured versus modeled
trough heights
Fibril rs (nm) w (nm) p (nm) rt* (nm) yt* (nm) yt
y (nm) yt
z (nm)
A 4.5 90.7 56.2 114.3 7.5 6.8 7.0
B 4.75 91.2 186.4 109.4 7.2 7.1 7.0
Fibrils A and B refer to the ﬁbrils highlighted in Fig. 2. Sample radius rs is
half the peak height; w was measured from the image as the average width
of 17 line proﬁles perpendicular to the ﬁbril; p, periodicity; rt, tip radius; yt,
trough height *from the convolution model; yfrom the hierarchical assem-
bly model; zas measured.
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